Cargando…

Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study

BACKGROUND: Fibroblast growth factor 23 (FGF23) plays an important role in chronic kidney disease (CKD)‐related mineral and bone disorders. High FGF23 levels are associated with increased risk of anaemia in non‐haemodialysis CKD patients. FGF23 also negatively regulates erythropoiesis in mice. We hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Usui, Tomoko, Zhao, Junhui, Fuller, Douglas S., Hanafusa, Norio, Hasegawa, Takeshi, Fujino, Hiroshi, Nomura, Takanobu, Zee, Jarcy, Young, Eric, Robinson, Bruce M., Nangaku, Masaomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754421/ https://www.ncbi.nlm.nih.gov/pubmed/32743932 http://dx.doi.org/10.1111/nep.13765

Ejemplares similares

Age and anemia management: relationship of hemoglobin levels with mortality might differ between elderly and nonelderly hemodialysis patients
por: Hanafusa, Norio, et al.
Publicado: (2014)

Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study
por: Komaba, Hirotaka, et al.
Publicado: (2020)

Japanese society for dialysis therapy renal data registry—a window through which we can view the details of Japanese dialysis population
por: Hanafusa, Norio, et al.
Publicado: (2015)

Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients
por: Kanai, Hidetoshi, et al.
Publicado: (2021)

Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients
por: Zee, Jarcy, et al.
Publicado: (2018)

Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study
por: Kikuchi, Kan, et al.
Publicado: (2021)

Extraperitoneal Placement of a Peritoneal Dialysis Catheter
por: Nakamura, Yasuna, et al.
Publicado: (2018)

Testing the Feasibility and Usability of a Novel Smartphone-Based Self-Management Support System for Dialysis Patients: A Pilot Study
por: Hayashi, Aki, et al.
Publicado: (2017)

Peritoneal Dialysis-Related Peritonitis Caused by Streptococcus oralis
por: Kotani, Akihiro, et al.
Publicado: (2021)

Prognostic Importance of Fibroblast Growth Factor-23 in Dialysis Patients
por: Akalin, Nilgül, et al.
Publicado: (2014)

Early Mortality Was Highly and Strongly Associated with Functional Status in Incident Japanese Hemodialysis Patients: A Cohort Study of the Large National Dialysis Registry
por: Yazawa, Masahiko, et al.
Publicado: (2016)

Effect of membrane dialysis and filtration-sterilization on erythropoietin activity.
por: Gallicchio, V. S., et al.
Publicado: (1981)

Correction: Early Mortality Was Highly and Strongly Associated with Functional Status in Incident Japanese Hemodialysis Patients: A Cohort Study of the Large National Dialysis Registry
por: Yazawa, Masahiko, et al.
Publicado: (2016)

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
por: Hamasaki, Yoshifumi, et al.
Publicado: (2014)

Do diabetic dialysis patients require more or less of erythropoietin?
por: Mitwalli, Ahmad, et al.
Publicado: (2013)

Prognostic significance of concentric left ventricular hypertrophy at peritoneal dialysis initiation
por: Tomura, Misato, et al.
Publicado: (2021)

Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS
por: Davies, Simon J., et al.
Publicado: (2020)

The Predictive Parameters of Erythropoietin Hyporesponsiveness in Patients on Continuous Ambulatory Peritoneal Dialysis
por: Kim, Jeong Ki, et al.
Publicado: (2001)

Twice-Weekly Hemodialysis and Clinical Outcomes in the China Dialysis Outcomes and Practice Patterns Study
por: Yan, Yucheng, et al.
Publicado: (2018)

Two long‐term phase 3 studies of enarodustat (JTZ‐951) in Japanese anemic patients with chronic kidney disease not on dialysis or on maintenance hemodialysis: SYMPHONY ND‐Long and HD‐Long studies
por: Akizawa, Tadao, et al.
Publicado: (2021)

A Phase 3 Study of Enarodustat in Anemic Patients with CKD not Requiring Dialysis: The SYMPHONY ND Study
por: Akizawa, Tadao, et al.
Publicado: (2021)

Hospitalization for Patients on Combination Therapy With Peritoneal Dialysis and Hemodialysis Compared With Hemodialysis
por: Tanaka, Mototsugu, et al.
Publicado: (2020)

Clinical frailty assessment might be associated with mortality in incident dialysis patients
por: Oki, Rikako, et al.
Publicado: (2022)

Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study
por: Yamamoto, Suguru, et al.
Publicado: (2020)

Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study
por: Kanda, Eiichiro, et al.
Publicado: (2017)

Calcium homeostasis in red blood cells of dialysis patients in dependence of erythropoietin treatment
por: Wang, Jue, et al.
Publicado: (2014)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Bae, Myoung Nam, et al.
Publicado: (2015)

Association of Neutrophil-to-Lymphocyte Ratio With Inflammation and Erythropoietin Resistance in Chronic Dialysis Patients
por: Pineault, Jérôme, et al.
Publicado: (2017)

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study
por: Narita, Ichiei, et al.
Publicado: (2022)

Time until treatment initiation is associated with catheter survival in peritoneal dialysis-related peritonitis
por: Oki, Rikako, et al.
Publicado: (2021)

Catheter Diversion Procedure With Exit-Site Renewal Promotes Peritoneal Dialysis Catheter Survival
por: Oki, Rikako, et al.
Publicado: (2020)

Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study
por: Karaboyas, Angelo, et al.
Publicado: (2018)

Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis
por: Murashima, Miho, et al.
Publicado: (2023)

Effects of Erythropoietin Payment Policy on Cardiovascular Outcomes of Peritoneal Dialysis Patients: Observational Study
por: Hou, Ying-Hui, et al.
Publicado: (2020)

Effects of Low-Flux and High-Flux Dialysis Membranes on Erythropoietin Responsiveness in Hemodialysis Patients
por: Abdelhamid, Walid A. R., et al.
Publicado: (2022)

Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients
por: Sharma, Shailendra, et al.
Publicado: (2013)

Sex-Specific Differences in Mortality and Incident Dialysis in the Chronic Kidney Disease Outcomes and Practice Patterns Study
por: Hecking, Manfred, et al.
Publicado: (2021)

Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan
por: Nangaku, Masaomi, et al.
Publicado: (2020)

Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease
por: Hasegawa, Takeshi, et al.
Publicado: (2023)

Comparison of risk of peritoneal dialysis-associated peritonitis between roxadustat and recombinant human erythropoietin in peritoneal dialysis patients: a retrospective comparative cohort study
por: Zhang, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rglmlnrjvntf6js4cqegipb02s